EPITALON VS THYMOSIN α-1
Epitalon and Thymosin alpha-1 are two of the most-asked longevity / immune research peptides, with completely different lineages. Epitalon is a synthetic 4-aa Khavinson tetrapeptide (Ala-Glu-Asp-Gly) developed at the St. Petersburg Institute of Bioregulation and Gerontology for pineal-axis longevity research. Thymosin alpha-1 (Tα1) is a 28-aa thymic peptide approved as Zadaxin in 35+ countries as an immunomodulator.
SIDE BY SIDE
WHICH IS BETTER · BY GOAL
Thymosin alpha-1 has Phase 3 trials supporting Zadaxin approval in 35+ countries. Epitalon evidence is dominated by Khavinson-group Russian-language work without comparable Western RCT replication.
Epitalon is the canonical research peptide in the Khavinson pineal-axis longevity tradition. Thymosin alpha-1 is not specifically a longevity compound.
Thymosin alpha-1 has documented TLR9 agonism, dendritic-cell maturation, and T-cell + NK-cell activation. Epitalon does not have a characterized immune mechanism.
Khavinson 2003 reported telomerase upregulation in human peripheral blood lymphocytes with epitalon. Thymosin alpha-1 does not engage the telomerase axis.
STACKING NOTE
Epitalon and Thymosin alpha-1 act on different systems (pineal/telomerase vs immune) and are not commonly co-administered in published research. Both are used as standalone reference compounds within their respective categories.
SOURCED FROM GIGACOMPOUNDS
Both compounds are available as research-grade material at GigaCompounds · ≥99% purity · per-batch CoA. For laboratory research use only.

